Helius Medical Technologies Inc - Ordinary Shares - Class A
HSDT
Get informed when a big investor buys or sells
+ FollowMarket Cap$111.23M
Close$
$-2.15
245.4% downside
Current Fair Value
245.4% downsideOvervalued by 245.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $111.23 Million |
|---|---|
| Enterprise Value | $106.83 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.85 |
| Beta | 1.07 |
| Outstanding Shares | 76,736,156 |
Return
| Return on Equity | -69.15% |
|---|---|
| Return on Assets | -68.18% |
| Return on Invested Capital | -68.65% |
Valuation & Multiples
| P/E Ratio | -1.07 |
|---|---|
| PEG | -0.04 |
| Price to Sales | - |
| Price to Book Ratio | 0.74 |
| Enterprise Value to Revenue | 11.14 |
| Enterprise Value to EBIT | -0.79 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$3.40 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$3.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3077▲ 16.74% |
|---|---|
| Total Calls | 118,300▼ 79.68% |
| Total Puts | 36,400▼ 55.45% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 69.39%▼ 381.82% |
|---|---|
| Total Invested | $26.47M▼ 23.02% |
| Investors Holding | 51▲ 4.00% |
ESG Score
No data
About Helius Medical Technologies Inc
19 employees
CEO: Philippe Deschamps Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. ...